Advertisement

European Concerted Action in PET — Activities in Radiochemistry

  • Victor W. Pike
  • Gerhard Stöcklin

Abstract

Positron Emission Tomography (PET) is becoming an increasingly important tool for studying physiological, biochemical and pharmacological functions at a molecular level in living man, whether in health or in disease. More than a hundred PET groups have been established worldwide, about thirty of which are in Western Europe. From 1989 the European Community (EC), through its Medical and Health Research Programme, has sponsored a Concerted Action on ‘PET Investigations of Cellular Regeneration and Degeneration’ under the overall coordination of Dr Dominique Comar (Liège). The main aims of this Concerted Action are to foster greater contact between European PET centres, to standardise PET methodology wherever possible (and thereby, for example, to allow results from different centres to be compared or even pooled within collaborative projects) and also to educate the many newcomers to PET in state-of-the-art techniques. The Concerted Action is not wholly restricted to PET groups within EC member states. For example, the Concerted Action is also open to PET groups in other European countries participating in the COST (Cooperation on Science and Technology) programme (e.g. Sweden).

Keywords

Positron Emission Tomography Positron Emission Tomography Study Task Group Concert Action Label Amino Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Baron, J.V., Cornar, D., Farde, L., Martinot, J.L., and Mazoyer B. (Eds), 1991, Brain Dopaminergic Systems. Imaging with Positron Emission Tomography. Kluwer Academic Publishers, Dordrecht, Boston, London.Google Scholar
  2. Clark, J.C., Crouzel, C., Meyer, G-J., and Strijckmans, K., 1987, Current methodology for oxygen-15 production for clinical use, Appl. Radiat. Isot., 38: 597.CrossRefGoogle Scholar
  3. Coenen, H.H., Pike, V.W., Stöcklin, G. and Wagner, R., 1987, Recommendation for a practical production of [2-18F]fluoro-2-deoxy-D-glucose, Appl. Radiat. Isot., 38: 605.CrossRefGoogle Scholar
  4. Crouzel, C., Långstrüm, B., Pike, V.W. and Coenen, H.H., 1987, Recommendations for a practical production of [11C]methyl iodide, Appl. Radiat, Isot., 38: 601.CrossRefGoogle Scholar
  5. Crouzel, C., Guillaume, M., Barré, L., Lemaire, C., and Pike, V.W., 1992, Ligands and tracers for PET studies of the 5-HT system — current status, Nucl. Med. Biol., 19: 857.Google Scholar
  6. Crouzel, C., Clark, J.C., Brihaye, C., Långstrüm, B., Lemaire, C., Meyer, G-J., Nebeling, B., and Stone-Elander S., 1993, Radiochemistry automation for PET. In Radiopharmaceuticals for Positron Emission Tomography — Methodological Aspects. Stöcklin, G., and Pike, V.W. (Eds). Kluwer Academic Publishers, Dordrecht, Boston, London.Google Scholar
  7. Delforge, J., Syrota, A., Lancon, J-P., Nakajima, K., Loch, C., Janier, M., Vallois, J-M., Cayla J., and Crouzel, C., 1991, Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method, J. Nucl. Med., 32:739.PubMedGoogle Scholar
  8. Guillaume, M., Luxen, A., Nebeling, B., Argentini, M., Clark, J.C., and Pike, V.W., 1991, Recommendations for fluorine-18 production, Appl. Radiat. Isot., 42: 749.CrossRefGoogle Scholar
  9. Jones H.A., Rhodes C.G., Law, M.P., Becket, J.M., Clark, J.C., Boobis, A.R., and Taylor, G. W., 1991, rapid analysis for metabolites of nC-labelled drugs: fate of [11C]-S-4-(tert.-butylamino-2-hydroxypropoxy)-benzimidazol-2-one in the dog, J. Chromatography, 570:361.Google Scholar
  10. Luthra, S.K., Osman, S., Steel C.J., Law M.P., Rhodes, C.G., Vaja V., Ahier, R., Brady, F., Waters, S.L., De Silva, R., Hughes, J.M.B., and Camici, P.G., 1993, Comparison of S-[11C]CGP 12177 metabolism in rat, dog, and man using solid phase extraction and HPLC, J. Label. Compd. Ratiopharm., 32:504.Google Scholar
  11. Luxen, A., Guillaume, M., Melega, W.P., Pike, V.W., Solin, O., and Wagner R., 1992, Production of 6-[18F]fluoro-L-DOPA and its metabolism in vivo — a critical review, Nucl. Med. Biol., 19:149.Google Scholar
  12. Mazoyer, B.M., Heiss, W.D., and Comar, D. (Eds)., 1993, PET Studies on Amino Acid Metabolism and Protein Synthesis. Kluwer Academic Publishers, Dordrecht, Boston, London.Google Scholar
  13. Mazière, B., Coenen, H.H., Halldin, C., Någren, K., and Pike V.W., 1992, PET radioligands for dopamine receptors and re-uptake sites: chemistry and biochemistry, Nucl. Med. Biol, 19:497.Google Scholar
  14. Mazière, B., Cantineau, R., Coenen, H.H., Guillaume, M., Halldin, C., Luxen, A., Loch, C., and Luthra, S.K., 1993, PET radiopharmaceutical metabolism— plasma metabolite analysis, In Radiopharmaceuticals for Positron Emission Tomography—Methodological Aspects. Stöcklin G., and Pike, V.W. (Eds). Kluwer Academic Publishers, Dordrecht, Boston, London. In press.Google Scholar
  15. Meyer, G-J., Coenen, H.H., Waters, S.L., Långström, B., Cantineau, R., Strijckmans, K., Vaalburg, W., Halldin, C., Crouzel, C., Mazière, B., and Luxen, A., 1993, Quality assurance and quality control of short-lived radiopharmaceuticals for PET. In Radiopharmaceuticals for Positron Emission Tomography — Methodological Aspects. Stöcklin, G., and Pike, V.W. (Eds). Kluwer Academic Publishers, Dordrecht, Boston, London. In press.Google Scholar
  16. Pike, V.W., Halldin, C., Crouzel, C., Barré, L., Nutt, D.J., Osman, S., Shah, F., Turton, D.R., and Waters S.L., 1993, Radioligands for PET studies of central benzodiazepine receptors and PK (peripheral benzodiazepine) binding-sites — current status, Nucl. Med. Biol, 20:503.PubMedCrossRefGoogle Scholar
  17. Qaim, S.M., Clark, J.C., Crouzel, C., Guillaume, M., Helmeke, H.J., Nebeling, B., Pike V.W., and Stöcklin, G., 1993, PET radionuclide production, in Radiopharmaceuticals for Positron Emission Tomography — Methodological Aspects. Stöcklin, G., and Pike, V.W. (Eds). Kluwer Academic Publishers, Dordrecht, Boston, London.Google Scholar
  18. Stöcklin, G., and Pike, V.W. (Eds), 1993, Radiopharmaceuticals for Positron Emission Tomography — Methodological Aspects, Kluwer Academic Publishers, Dordrecht, Boston, London.Google Scholar
  19. Vaalburg, W., Coenen, H.H., Crouzel, C., Elsinga, Ph.H., Långström, B., Lemaire, C., and Meyer, G-J., 1992, Amino acids for the measurement of protein synthesis in vivo by PET. Nucl. Med. Biol., 19:227.Google Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Victor W. Pike
    • 1
  • Gerhard Stöcklin
    • 2
  1. 1.MRC Cyclotron UnitHammersmith HospitalLondonUK
  2. 2.Institüt für NuklearchemieForschungszentrum Jülich GmbHJülichGermany

Personalised recommendations